rs151102225
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_004425.4(ECM1):c.1100A>T(p.Asp367Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00987 in 1,612,804 control chromosomes in the GnomAD database, including 99 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0073 ( 7 hom., cov: 27)
Exomes 𝑓: 0.010 ( 92 hom. )
Consequence
ECM1
NM_004425.4 missense
NM_004425.4 missense
Scores
3
10
5
Clinical Significance
Conservation
PhyloP100: 2.59
Publications
8 publications found
Genes affected
ECM1 (HGNC:3153): (extracellular matrix protein 1) This gene encodes a soluble protein that is involved in endochondral bone formation, angiogenesis, and tumor biology. It also interacts with a variety of extracellular and structural proteins, contributing to the maintenance of skin integrity and homeostasis. Mutations in this gene are associated with lipoid proteinosis disorder (also known as hyalinosis cutis et mucosae or Urbach-Wiethe disease) that is characterized by generalized thickening of skin, mucosae and certain viscera. Alternatively spliced transcript variants encoding distinct isoforms have been described for this gene. [provided by RefSeq, Feb 2011]
ECM1 Gene-Disease associations (from GenCC):
- lipoid proteinosisInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, G2P, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.015558243).
BP6
Variant 1-150512368-A-T is Benign according to our data. Variant chr1-150512368-A-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 376771.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00728 (1098/150920) while in subpopulation NFE AF = 0.0117 (792/67776). AF 95% confidence interval is 0.011. There are 7 homozygotes in GnomAd4. There are 528 alleles in the male GnomAd4 subpopulation. Median coverage is 27. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ECM1 | NM_004425.4 | c.1100A>T | p.Asp367Val | missense_variant | Exon 8 of 10 | ENST00000369047.9 | NP_004416.2 | |
| ECM1 | NM_001202858.2 | c.1181A>T | p.Asp394Val | missense_variant | Exon 8 of 10 | NP_001189787.1 | ||
| ECM1 | NM_022664.3 | c.725A>T | p.Asp242Val | missense_variant | Exon 7 of 9 | NP_073155.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00729 AC: 1099AN: 150802Hom.: 7 Cov.: 27 show subpopulations
GnomAD3 genomes
AF:
AC:
1099
AN:
150802
Hom.:
Cov.:
27
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00729 AC: 1828AN: 250644 AF XY: 0.00749 show subpopulations
GnomAD2 exomes
AF:
AC:
1828
AN:
250644
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0101 AC: 14825AN: 1461884Hom.: 92 Cov.: 32 AF XY: 0.00993 AC XY: 7221AN XY: 727244 show subpopulations
GnomAD4 exome
AF:
AC:
14825
AN:
1461884
Hom.:
Cov.:
32
AF XY:
AC XY:
7221
AN XY:
727244
show subpopulations
African (AFR)
AF:
AC:
48
AN:
33480
American (AMR)
AF:
AC:
156
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
418
AN:
26136
East Asian (EAS)
AF:
AC:
0
AN:
39700
South Asian (SAS)
AF:
AC:
517
AN:
86258
European-Finnish (FIN)
AF:
AC:
322
AN:
53420
Middle Eastern (MID)
AF:
AC:
5
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
12809
AN:
1112002
Other (OTH)
AF:
AC:
550
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
901
1802
2702
3603
4504
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
476
952
1428
1904
2380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00728 AC: 1098AN: 150920Hom.: 7 Cov.: 27 AF XY: 0.00717 AC XY: 528AN XY: 73632 show subpopulations
GnomAD4 genome
AF:
AC:
1098
AN:
150920
Hom.:
Cov.:
27
AF XY:
AC XY:
528
AN XY:
73632
show subpopulations
African (AFR)
AF:
AC:
83
AN:
41088
American (AMR)
AF:
AC:
91
AN:
15044
Ashkenazi Jewish (ASJ)
AF:
AC:
55
AN:
3452
East Asian (EAS)
AF:
AC:
0
AN:
5124
South Asian (SAS)
AF:
AC:
22
AN:
4696
European-Finnish (FIN)
AF:
AC:
48
AN:
10440
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
792
AN:
67776
Other (OTH)
AF:
AC:
7
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
54
108
161
215
269
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
49
ALSPAC
AF:
AC:
55
ESP6500AA
AF:
AC:
11
ESP6500EA
AF:
AC:
94
ExAC
AF:
AC:
939
Asia WGS
AF:
AC:
6
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Dec 30, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
ECM1: BS1, BS2 -
Lipid proteinosis Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Uncertain
.;D;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
.;M;.
PhyloP100
PrimateAI
Benign
T
PROVEAN
Pathogenic
D;D;D
REVEL
Uncertain
Sift
Uncertain
D;D;D
Sift4G
Pathogenic
D;D;D
Polyphen
D;D;D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.